(Q35566005)

8 August 2017

title

Norfloxacin binds to human fecal material (English)

1 reference

8 August 2017

0 references

Edlund C

1

1 reference

8 August 2017

Lindqvist L

series ordinal

2

1 reference

8 August 2017

Nord CE

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 December 1988

1 reference

Antimicrobial Agents and Chemotherapy

8 August 2017

published in

1 reference

8 August 2017

volume

32

1 reference

8 August 2017

issue

12

1 reference

8 August 2017

page(s)

1869-1874

1 reference

The microbial contribution to human faecal mass

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Investigations into the mechanism of action of the antibacterial agent norfloxacin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Binding to and antibacterial effect of aztreonam, temocillin, gentamicin and tobramycin on human faeces

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Routes of quinolone permeation in Escherichia coli

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Endogenous active efflux of norfloxacin in susceptible Escherichia coli

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Mode of action of the quinolone antimicrobial agents.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Accumulation of enoxacin by Escherichia coli and Bacillus subtilis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Antibacterial activity of norfloxacin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176035

Effects of norfloxacin on the faecal flora in patients with complicated urinary tract infections

26 September 2018

1 reference

12 December 2020

Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics

1 reference

12 December 2020

Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal

1 reference

12 December 2020

Reversible binding of polymyxin B and neomycin to the solid part of faeces

1 reference

12 December 2020

Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.32.12.1869

1 reference

8 August 2017

1 reference

8 August 2017

1 reference